• Citer

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

par Dixon-Douglas, Julia R;Drubay, Damien;Salgado, Roberto;Acs, Balazs;van der Laak, Jeroen;Yuan, Yinyin;Amgad, Mohamed;Cooper, Lee;Hagos, Yeman;AbdulJabbar, Khalid;Meakin, James;van Ginneken, Bram;Yan, Haixi;Lemonnier, Jerome;Penault-Llorca, Frédérique;Lacroix-Triki, Magali;Joensuu, Heikki;Kellokumpu-Lehtinen, Pirkko-Liisa;Loibl, Sybille;Denkert, Carsten;Viale, Giuseppe;Colleoni, Marco Angelo;Sotiriou, Christos ;Piccart, Martine;Dieci, Maria Vittoria;Demaria, Sandra;Kammler, Roswitha;Wolff, Antonio C;Sparano, Joseph A;Adams, Sylvia;Badve, Sunil;Gray, Robert James R.;Curigliano, Giuseppe;Salomon, Anne Vincent;Nielsen, Torsten O;Pusztai, Lajos;Ciompi, Francesco;Michiels, Stefan ;Loi, Sherene ;International Immuno-Oncology Biomarker Working Group,
Référence Lancet oncology, 27, 9, page (1181-1192)
Publication Publié, 2026-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
Auteur:	Dixon-Douglas, Julia R; Drubay, Damien; Salgado, Roberto; Acs, Balazs; van der Laak, Jeroen; Yuan, Yinyin; Amgad, Mohamed; Cooper, Lee; Hagos, Yeman; AbdulJabbar, Khalid; Meakin, James; van Ginneken, Bram; Yan, Haixi; Lemonnier, Jerome; Penault-Llorca, Frédérique; Lacroix-Triki, Magali; Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Loibl, Sybille; Denkert, Carsten; Viale, Giuseppe; Colleoni, Marco Angelo; Sotiriou, Christos; Piccart, Martine; Dieci, Maria Vittoria; Demaria, Sandra; Kammler, Roswitha; Wolff, Antonio C; Sparano, Joseph A; Adams, Sylvia; Badve, Sunil; Gray, Robert James R.; Curigliano, Giuseppe; Salomon, Anne Vincent; Nielsen, Torsten O; Pusztai, Lajos; Ciompi, Francesco; Michiels, Stefan; Loi, Sherene; International Immuno-Oncology Biomarker Working Group,
Informations sur la publication:	Lancet oncology, 27, 9, page (1181-1192)
Statut de publication:	Publié, 2026-09
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Humans
	Female
	Triple Negative Breast Neoplasms -- pathology -- immunology -- mortality -- therapy
	Lymphocytes, Tumor-Infiltrating -- pathology -- immunology
	Artificial Intelligence
	Prognosis
	Middle Aged
	Reproducibility of Results
	Prospective Studies
	Disease-Free Survival
	Aged
	Randomized Controlled Trials as Topic
	Adult
	ROC Curve
Langue:	Anglais
Identificateurs:	urn:issn:1470-2045
	info:doi/10.1016/S1470-2045(26)00339-6
	info:pii/S1470-2045(26)00339-6
	info:pmid/42636839
	PMC13644576